Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]

View source ↗

Summary

This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves survival in common no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University College, London | Conditions: Cancer, Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING